Summary
Researchers reviewed the anti-inflammatory activity of Rubia cordifolia, a plant known in traditional medicine. The review covered several studies that demonstrated how bioactive compounds present in the plant, such as alizarin and rubiadin, act in modulating inflammatory mediators. The authors, including Kirti Naharwal and Dr. Puja Maldhure, highlighted that Rubia cordifolia can inhibit the production of inflammatory cytokines and the activation of immune cells, suggesting a therapeutic potential in inflammatory conditions. Although the results are promising, most studies were conducted in vitro or in animal models, which limits the generalization of the findings to humans. The review also discusses the importance of further clinical research to validate these effects and explore the application of the plant in clinical practice.
Key points
- Compounds such as alizarin and rubiadin have been shown to inhibit the production of inflammatory cytokines.
- Rubia cordifolia may modulate the activation of immune cells, suggesting a role in reducing inflammation.
- Most of the reviewed studies were conducted in vitro or in animal models, limiting clinical applicability.
✦ For you
If you are interested in reducing inflammation in your body, consider including foods and teas that contain Rubia cordifolia in your diet. Observe how your body reacts to these additions and keep a symptom diary. If you experience persistent discomfort, seek a qualified healthcare professional.
For practitionersExpand
Consider including Rubia cordifolia (Rubiaceae) in formulas for patients with inflammatory conditions. Assess the patient's response and adjust the dosage as needed, taking into account that the current evidence is based mainly on preclinical studies.